Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136


Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer.

Wunderle M, Pretscher J, Brucker SY, Volz B, Hartmann A, Fiessler C, Hein A, Häberle L, Jud SM, Lux MP, Janni W, Loehberg CR, Hartkopf AD, Walter CB, Baake G, Fridman A, Malter W, Wuerstlein R, Harbeck N, Hoffmann O, Kümmel S, Martin B, Thomssen C, Graf H, Wolf C, Bayer CM, Hack CC, Almstedt K, Gass P, Heindl F, Brodkorb TF, Nabieva N, Lindner C, Kolberg HC, Krabisch P, Weigel M, Steinfeld-Birg D, Kohls A, Brucker C, Schulz V, Fischer G, Pelzer V, Wallwiener D, Rack B, Fehm T, Rody A, Maass N, Beckmann MW, Fasching PA, Rauh C.

Breast Cancer Res Treat. 2019 Jan 2. doi: 10.1007/s10549-018-05115-6. [Epub ahead of print]


Catheter-related Complications of Subcutaneous Implantable Venous Access Devices in Breast Cancer Patients.

El-Balat A, Schmeil I, Karn T, Holtrich U, Mavrova-Risteska L, Rody A, Youssef A, Hanker LC.

In Vivo. 2018 Sep-Oct;32(5):1275-1281. doi: 10.21873/invivo.11377.


Molecular Tumor Boards.

Rody A, Ettl J, Marmé F, Prat A.

Breast Care (Basel). 2018 Apr;13(2):141-143. doi: 10.1159/000489138. Epub 2018 Apr 23. No abstract available.


Neural Tube Defects in Embryonic Life: Lessons Learned From 340 Early Pregnancy Failures.

Hartge DR, Gembicki M, Rody A, Weichert J.

J Ultrasound Med. 2018 Dec;37(12):2841-2847. doi: 10.1002/jum.14642. Epub 2018 Apr 17.


Effects of Combined Treatment with Vitamin D and COX2 Inhibitors on Breast Cancer Cell Lines.

Friedrich M, Reichert K, Woeste A, Polack S, Fischer D, Hoellen F, Rody A, Köster F, Thill M.

Anticancer Res. 2018 Feb;38(2):1201-1207.


Excisions of severe cervical dysplasia: Are there mandatory diameters of the cone that need to be considered?

Beyer DA, Rody A, Schmidt N, Cirkel C, Neumann K.

J Turk Ger Gynecol Assoc. 2017 Dec 15;18(4):185-189. doi: 10.4274/jtgga.2017.0036.


Is surgical plume developing during routine LEEPs contaminated with high-risk HPV? A pilot series of experiments.

Neumann K, Cavalar M, Rody A, Friemert L, Beyer DA.

Arch Gynecol Obstet. 2018 Feb;297(2):421-424. doi: 10.1007/s00404-017-4615-2. Epub 2017 Dec 13.


Claudin-1 expression in cervical cancer.

Hoellen F, Waldmann A, Banz-Jansen C, Holtrich U, Karn T, Oberländer M, Habermann JK, Hörmann M, Köster F, Ribbat-Idel J, Thill M, Rody A, El-Balat A, Hanker L.

Mol Clin Oncol. 2017 Nov;7(5):880-884. doi: 10.3892/mco.2017.1391. Epub 2017 Aug 25.


Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017).

Untch M, Huober J, Jackisch C, Schneeweiss A, Brucker SY, Dall P, Denkert C, Fasching PA, Fehm T, Gerber B, Janni W, Kühn T, Lüftner D, Möbus V, Müller V, Rody A, Sinn P, Thill M, Thomssen C, Harbeck N, Liedtke C.

Geburtshilfe Frauenheilkd. 2017 Jun;77(6):633-644. doi: 10.1055/s-0043-111601. Epub 2017 Jun 28.


Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer.

Karn T, Jiang T, Hatzis C, Sänger N, El-Balat A, Rody A, Holtrich U, Becker S, Bianchini G, Pusztai L.

JAMA Oncol. 2017 Dec 1;3(12):1707-1711. doi: 10.1001/jamaoncol.2017.2140.


Mandatory colposcopic findings of severe cervical dysplasia. Are there key-signs that need our special attention?

Beyer DA, Rody A, Cirkel C, Schmidt N, Neumann K.

J Gynecol Obstet Hum Reprod. 2017 Oct;46(8):643-646. doi: 10.1016/j.jogoh.2017.07.002. Epub 2017 Jul 8.


C-Section Prevalence Among Obese Mothers and Neonatal Hypoglycemia: a Cohort Analysis of the Department of Gynecology and Obstetrics of the University of Lübeck.

Neumann K, Indorf I, Härtel C, Cirkel C, Rody A, Beyer DA.

Geburtshilfe Frauenheilkd. 2017 May;77(5):487-494. doi: 10.1055/s-0043-108763. Epub 2017 May 24.


Implementation of the Recommendation to Vaccinate Pregnant Women against Seasonal Influenza - Vaccination Rates and Acceptance.

Baum S, Hitschold T, Becker A, Smola S, Solomayer E, Rody A, Rissland J.

Geburtshilfe Frauenheilkd. 2017 Apr;77(4):340-351. doi: 10.1055/s-0043-103970.


[Utility Analysis of Oncological Centre Building in the Field of Colorectal Cancer].

Weinhold I, Keck T, Merseburger A, Rody A, Wollenberg B, Wende D, Häckl D, Elsner C.

Zentralbl Chir. 2018 Apr;143(2):181-192. doi: 10.1055/s-0042-122854. Epub 2017 May 4. German.


Delivery mode and intraventricular hemorrhage risk in very-low-birth-weight infants: Observational data of the German Neonatal Network.

Humberg A, Härtel C, Paul P, Hanke K, Bossung V, Hartz A, Fasel L, Rausch TK, Rody A, Herting E, Göpel W; German Neonatal Network (GNN).

Eur J Obstet Gynecol Reprod Biol. 2017 May;212:144-149. doi: 10.1016/j.ejogrb.2017.03.032. Epub 2017 Mar 22.


Neoadjuvant Therapy for Patients with Triple Negative Breast Cancer (TNBC).

Liedtke C, Rody A.

Rev Recent Clin Trials. 2017;12(2):73-80. doi: 10.2174/1574887112666170307095945.


Effects of an Antagonistic Analog of Growth Hormone-Releasing Hormone on Endometriosis in a Mouse Model and In Vitro.

Köster F, Jin L, Shen Y, Schally AV, Cai RZ, Block NL, Hornung D, Marschner G, Rody A, Engel JB, Finas D.

Reprod Sci. 2017 Nov;24(11):1503-1511. doi: 10.1177/1933719117691140. Epub 2017 Feb 16.


What Are the Advantages of 3D Cameras in Gynaecological Laparoscopy?

Baum S, Sillem M, Ney JT, Baum A, Friedrich M, Radosa J, Kramer KM, Gronwald B, Gottschling S, Solomayer EF, Rody A, Joukhadar R.

Geburtshilfe Frauenheilkd. 2017 Jan;77(1):45-51. doi: 10.1055/s-0042-120845.


Do ART patients face higher C-section rates during their stage of delivery? A German monocenter experience.

Neumann K, Cirkel C, Rody A, Beyer DA.

Arch Gynecol Obstet. 2017 Feb;295(2):481-485. doi: 10.1007/s00404-016-4252-1. Epub 2016 Dec 7.


Trefoil factor 3 expression in epithelial ovarian cancer exerts a minor effect on clinicopathological parameters.

Hoellen F, Kostara A, Karn T, Holtrich U, El-Balat A, Otto M, Rody A, Hanker LC.

Mol Clin Oncol. 2016 Oct;5(4):422-428. Epub 2016 Aug 17.


Expression of cyclooxygenase-2 in cervical cancer is associated with lymphovascular invasion.

Hoellen F, Waldmann A, Banz-Jansen C, Rody A, Heide M, Köster F, Ribbat-Idel J, Thorns C, Gebhard M, Oberländer M, Habermann JK, Thill M.

Oncol Lett. 2016 Oct;12(4):2351-2356. Epub 2016 Jul 29.


Treatment-Associated Anxiety among Pregnant Women and their Partners: What is the Influence of Sex, Parity, Age and Education?

Kannenberg K, Weichert J, Rody A, Banz-Jansen C.

Geburtshilfe Frauenheilkd. 2016 Jul;76(7):809-813.


Subtypes of Triple-negative Breast Cancer Cell Lines React Differently to Eribulin Mesylate.

Bräutigam K, Mitzlaff K, Uebel L, Köster F, Polack S, Pervan M, Steinert G, Rody A, Liedtke C.

Anticancer Res. 2016 Jun;36(6):2759-66.


Disrupting Y-Box-Binding Protein 1 Function Using OSU-03012 Prevents Endometriosis Progression in In Vitro and In Vivo Models.

Silveira CGT, Marschner G, Canny GO, Klocke S, Hunold P, Köster F, Ahrens T, Rody A, Hornung D.

Reprod Sci. 2017 Jan;24(1):67-76. doi: 10.1177/1933719116649695. Epub 2016 Sep 27.


Introducing a new scoring system for pap smear in the detection of high-grade squamous intraepithelial lesions in pregnancy (The Luebeck Score).

Neumann K, Barop C, Cirkel C, Rody A, Beyer DA.

Arch Gynecol Obstet. 2016 Oct;294(4):855-60. doi: 10.1007/s00404-016-4113-y. Epub 2016 May 14.


Her2-neu score as a prognostic factor for outcome in patients with triple-negative breast cancer.

Schmidt G, Gerlinger C, Juhasz-Böss I, Stickeler E, Rody A, Liedtke C, Wimberger P, Link T, Müller E, Fehm T, Abel M, Stein S, Bohle R, Endrikat J, Solomayer EF.

J Cancer Res Clin Oncol. 2016 Jun;142(6):1369-76. doi: 10.1007/s00432-016-2146-z. Epub 2016 Mar 23.


Management of Very Early-onset Fetal Growth Restriction: Results from 92 Consecutive Cases.

Hoellen F, Beckmann A, Banz-Jansen C, Weichert J, Rody A, Bohlmann MK.

In Vivo. 2016 Mar-Apr;30(2):123-31.


Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer.

Karn T, Rody A, Müller V, Schmidt M, Becker S, Holtrich U, Pusztai L.

Genom Data. 2014 Oct 23;2:354-6. doi: 10.1016/j.gdata.2014.09.014. eCollection 2014 Dec.


The Influence of Host Factors on the Prognosis of Breast Cancer: Stroma and Immune Cell Components as Cancer Biomarkers.

Karn T, Pusztai L, Rody A, Holtrich U, Becker S.

Curr Cancer Drug Targets. 2015;15(8):652-64. Review.


The prognostic impact of age in different molecular subtypes of breast cancer.

Liedtke C, Rody A, Gluz O, Baumann K, Beyer D, Kohls EB, Lausen K, Hanker L, Holtrich U, Becker S, Karn T.

Breast Cancer Res Treat. 2015 Aug;152(3):667-73. doi: 10.1007/s10549-015-3491-3. Epub 2015 Jul 21.


Evaluation of YB-1 levels in patients with endometriosis.

Ahrens T, Silveira CG, Banz-Jansen C, Rody A, Hornung D.

Eur J Obstet Gynecol Reprod Biol. 2015 Aug;191:68-71. doi: 10.1016/j.ejogrb.2015.05.008. Epub 2015 Jun 9.


Guideline conformity treatment in young women with early-onset breast cancer in Germany.

Pursche T, Hedderich M, Heinrichs A, Baumann K, Banz-Jansen C, Rody A, Waldmann A, Fischer D.

Breast Care (Basel). 2014 Oct;9(5):349-54. doi: 10.1159/000366435.


Vitamin D inhibits ovarian cancer cell line proliferation in combination with celecoxib and suppresses cyclooxygenase-2 expression.

Thill M, Woeste A, Reichert K, Fischer D, Rody A, Friedrich M, Köster F.

Anticancer Res. 2015 Feb;35(2):1197-203.


Combined treatment of breast cancer cell lines with vitamin D and COX-2 inhibitors.

Thill M, Reichert K, Woeste A, Polack S, Fischer D, Hoellen F, Rody A, Friedrich M, Köster F.

Anticancer Res. 2015 Feb;35(2):1189-95.


Genomic predictor of residual risk of recurrence after adjuvant chemotherapy and endocrine therapy in high risk estrogen receptor-positive breast cancers.

Khan SS, Karn T, Symmans WF, Rody A, Müller V, Holtrich U, Becker S, Pusztai L, Hatzis C.

Breast Cancer Res Treat. 2015 Feb;149(3):789-97. doi: 10.1007/s10549-015-3277-7. Epub 2015 Feb 5.


Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer.

Witzel I, Milde-Langosch K, Schmidt M, Karn T, Becker S, Wirtz R, Rody A, Laakmann E, Schütze D, Jänicke F, Müller V.

Onco Targets Ther. 2014 Nov 28;7:2205-13. doi: 10.2147/OTT.S65344. eCollection 2014.


New treatment strategies for patients with triple-negative breast cancer.

Liedtke C, Rody A.

Curr Opin Obstet Gynecol. 2015 Feb;27(1):77-84. doi: 10.1097/GCO.0000000000000137. Review.


Does maternal underweight prior to conception influence pregnancy risks and outcome?

Hoellen F, Hornemann A, Haertel C, Reh A, Rody A, Schneider S, Tuschy B, Bohlmann MK.

In Vivo. 2014 Nov-Dec;28(6):1165-70.


Identification of prognostic different subgroups in triple negative breast cancer by Her2-neu protein expression.

Schmidt G, Meyberg-Solomayer G, Gerlinger C, Juhasz-Böss I, Herr D, Rody A, Liedtke C, Solomayer EF.

Arch Gynecol Obstet. 2014 Dec;290(6):1221-9. doi: 10.1007/s00404-014-3331-4. Epub 2014 Jul 11.


OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancer.

Sänger N, Ruckhäberle E, Bianchini G, Heinrich T, Milde-Langosch K, Müller V, Rody A, Solomayer EF, Fehm T, Holtrich U, Becker S, Karn T.

Mol Oncol. 2014 Oct;8(7):1196-207. doi: 10.1016/j.molonc.2014.04.003. Epub 2014 Apr 15.


Assessment of University Gynaecology Clinics Based on Quality Reports.

Solomayer EF, Rody A, Wallwiener D, Beckmann MW.

Geburtshilfe Frauenheilkd. 2013 Jul;73(7):705-712.


Estrogen, progesterone, and Her-2/neu receptor expression discrepancy in primary tumors and in-breast relapse in patients with breast cancer.

Mavrova R, Radosa J, Schmitt K, Bohle RM, Rody A, Solomayer EF, Juhasz-Böess I.

Breast J. 2014 May-Jun;20(3):322-4. doi: 10.1111/tbj.12270. Epub 2014 Apr 11. No abstract available.


HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer.

Harbeck N, Beckmann MW, Rody A, Schneeweiss A, Müller V, Fehm T, Marschner N, Gluz O, Schrader I, Heinrich G, Untch M, Jackisch C.

Breast Care (Basel). 2013 Mar;8(1):49-55. doi: 10.1159/000346837. Review.


Genomic profiling in triple-negative breast cancer.

Liedtke C, Bernemann C, Kiesel L, Rody A.

Breast Care (Basel). 2013 Dec;8(6):408-13. doi: 10.1159/000357534. Review.


The role of lymphadenectomy in uterine sarcoma: a clinical practical approach based on retrospective analysis.

Hoellen F, Waldmann A, Benthin S, Hanker L, Rody A, Fischer D.

Anticancer Res. 2014 Feb;34(2):985-93.


13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013).

Untch M, Gerber B, Harbeck N, Jackisch C, Marschner N, Möbus V, von Minckwitz G, Loibl S, Beckmann MW, Blohmer JU, Costa SD, Decker T, Diel I, Dimpfl T, Eiermann W, Fehm T, Friese K, Jänicke F, Janni W, Jonat W, Kiechle M, Köhler U, Lück HJ, Maass N, Possinger K, Rody A, Scharl A, Schneeweiss A, Thomssen C, Wallwiener D, Welt A.

Breast Care (Basel). 2013 Jun;8(3):221-9. doi: 10.1159/000351692.


Hybrid approach of retractor-based and conventional laparoscopy enabling minimally invasive hysterectomy in a morbidly obese patient: case report and review of the literature.

Hoellen F, Rody A, Ros A, Bruns A, Cirkel C, Bohlmann MK.

Minim Invasive Ther Allied Technol. 2014 Jun;23(3):184-7. doi: 10.3109/13645706.2013.870577. Epub 2013 Dec 13. Review.


L1 cell adhesion molecule as a potential therapeutic target in murine models of endometriosis using a monoclonal antibody approach.

Silveira CG, Finas D, Hunold P, Köster F, Stroschein K, Canny GO, Moldenhauer G, Altevogt P, Rody A, Hornung D.

PLoS One. 2013 Dec 4;8(12):e82512. doi: 10.1371/journal.pone.0082512. eCollection 2013.


The impact of the body mass index (BMI) on laparoscopic hysterectomy for benign disease.

Bardens D, Solomayer E, Baum S, Radosa J, Gräber S, Rody A, Juhasz-Böss I.

Arch Gynecol Obstet. 2014 Apr;289(4):803-7. doi: 10.1007/s00404-013-3050-2. Epub 2013 Oct 11.


Supplemental Content

Support Center